corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8899

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

1970 Financial data for 264 drug field firms is shown
Drug Trade News 1971 Sep 20; 46:15-21


Abstract:

The data presented relates to sales, manufacturing cost, taxes on earnings, earnings after taxes and total assets of 264 companies active in the drug field. Based on this survey, the following conclusions are made: (1) manufacturers of diversified drug products reported increases in sales, earnings after taxes and assets when data for the year 1970 was compared with that of 1969; (2) sales of manufacturers of diversified drug products were up 8.5%, earnings after taxes, 6.9%, and assets 9.4%; (3) cosmetic and toiletry suppliers to the drug trade boosted sales 9.6% over 1969, profits were up an average of 9.9%; and (4) prescription and other professional products suppliers increased sales 12.5%.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.